Table 2

Descriptive statistics of hyperglycemic period characteristics

N13,594
Period length, mean (SD), months33.2 (28.1)
Initial HbA1c, mean (SD), %; mmol/mol8.3 (1.6); 67 (12.9)
Maximum HbA1c, mean (SD), %; mmol/mol9.4 (2.0); 79 (16.8)
Periods where treatment target was reached, n (%)8,300 (61.1)
Rate of HbA1c measurement per month−1, mean (SD)0.28 (0.16)
Rate of lifestyle counseling per month−1, mean (SD)0.30 (0.24)
Rate of medication intensification per month−1, mean (SD)0.10 (0.13)
Periods with patients receiving insulin, n (%)4,118 (30.3)
Periods with patients who are obese (BMI ≥30 kg/m2), n (%)7,549 (55.5)
Documentation heterogeneity, mean (SD)a0.69 (0.15)
Documentation intensity, mean (SD), characters/note91 (45)
  • aDocumentation heterogeneity represented by the normalized Levenshtein distance.